1.When Thyroid Meets Dengue and Hepatitis: A Case of Severe Thyrotoxicosis with Multiorgan Dysfunction
Shamila Sutharsan ; Yusniza Yusoff
Journal of the ASEAN Federation of Endocrine Societies 2026;41(S1):112-113
Introduction:
Severe thyrotoxicosis is an endocrine emergency that
may present with multiorgan dysfunction, particularly
when precipitated by systemic infection. Management
becomes challenging when hepatic injury limits the use of
standard antithyroid therapy. We report a case of severe
thyrotoxicosis with acute hepatitis in the setting of dengue
IgM positivity.
Case:
A 44-year-old male with chronic alcohol use presented with
epistaxis. On examination, he was deeply jaundiced and
had tremors on outstretched hands. Initial investigations
showed severe hepatitis with AST 2029 U/L, ALT 698 U/L,
total bilirubin 236 µmol/L, alkaline phosphatase 138 U/L,
and thrombocytopenia (34 ×10⁹/L). Viral hepatitis HBV,
HCV, HIV, and autoimmune hepatitis screen were negative.
Dengue IgM was positive.
Thyroid function tests demonstrated overt thyrotoxicosis
with free thyroxine 4 (FT4) 58.6 pmol/L and suppressed
thyroid-stimulating hormone.
He was managed as severe thyrotoxicosis with impending
thyroid crisis in view of systemic illness and multiorgan
involvement. Due to significant hepatic dysfunction, he
was treated with propranolol, dexamethasone, and lithium
carbonate 300 mg BD. Over 5 days, there was marked
clinical improvement with resolution of tachycardia and
tremors. FT4 decreased to 44.8 pmol/L. Liver function
tests improved significantly (AST 157 U/L, ALT 195 U/L,
bilirubin 163 µmol/L), and thrombocytopenia resolved
(platelets 323 ×10⁹/L). He remained hemodynamically stable
with normal Glasgow Coma Scale throughout admission.
Conclusion
This case highlights severe thyrotoxicosis with acute
hepatitis and dengue infection, where management
was complicated by contraindication to conventional
antithyroid therapy. Lithium and corticosteroids provided
effective biochemical and clinical improvement. Early
recognition and individualized therapy are crucial in
complex multisystem thyrotoxic presentations.
Hepatitis A
;
Thyrotoxicosis
;
Dengue
2.Economic evaluation of the WHO elimination strategy for hepatitis B for the Philippines.
Janus P. ONG ; Hilton Y. LAM ; Clarence C. YACAPIN ; Allan R. ULITIN ; Ma-ann M. ZARSUELO
Acta Medica Philippina 2025;59(14):60-74
BACKGROUND
The World Health Organization (WHO) estimates that in 2015, approximately 325 million or 4.4% of the global population were living with chronic hepatitis B or hepatitis C infection. In the same year, around 1.34 million died from this disease.
OBJECTIVESThis study aimed to estimate the burden of hepatitis B in the Philippines and to determine the costeffectiveness of possible interventions.
METHODSThis study utilized the Center for Disease Analysis Foundation’s (CDAF’s) mathematical disease burden model of hepatitis B. Model inputs were collected using literature review, key informant interviews, expert panel interviews, and records review, and were validated through a series of round table discussions with experts.
RESULTSResults show that in 2017, the prevalence of chronic hepatitis B infection in the Philippines was 9.7%, equivalent to 10 million infected individuals. Although the model projects a decreasing trend in chronic hepatitis B virus (HBV) infections, liver-related mortality and morbidity due to these viruses are expected to rise if the status quo is maintained. Results show that substantial increase in government subsidy for WHO elimination scenarios would be required to achieve cost-effective outcomes.
CONCLUSIONHepatitis B remains a huge problem in the Philippines. The HBV modelling exercise reveal that it will be worthwhile and cost-effective to adhere to the WHO elimination targets. A substantial financial investment will be necessary to do so, specifically a significant scale up in the screening, diagnosis, treatment, and monitoring of patients with HBV. While this modelling exercise does not yield burden of disease as accurate as a prevalence survey, experts consulted in the round table discussions agreed with the modelling inputs.
Human ; Hepatitis B ; Philippines ; Burden Of Disease ; Cost Of Illness
3.Measuring hepatitis B-related stigma: A systematic review of questionnaire-based studies.
Jaconiah Shelumiel T. MANALAYSAY ; Diego Nathaniel D. MINA ; Brian Arth M. URBANO ; Cathlyn B. GERALDO ; Josephine D. AGAPITO ; Janus P. ONG ; Joana Ophelia M. REAL ; Hilton Y. LAM
Acta Medica Philippina 2025;59(14):89-104
BACKGROUND AND OBJECTIVE
Stigma remains a profound barrier to public health, particularly in managing diseases such as Hepatitis B, which is highly prevalent in hyperendemic regions like the Philippines. The social stigma associated with such health conditions can severely limit access to care and hinder adherence to treatment, exacerbating the overall disease burden. Despite the critical impact of stigma on health outcomes, there is a notable gap in the systematic evaluation of the tools used to measure stigma related to health conditions like Hepatitis B. This study aims to fill this gap by reviewing existing instruments for their methodologies, reliability, and validity to inform the development of a refined tool tailored to the Philippine context.
METHODSA systematic search was conducted across six databases, including PubMed, Cochrane Database of Systematic Reviews, Open Grey, DissOnline, Philippine Health Research Registry (PHRR), and Health Research and Development Information Network (HERDIN), following PRISMA guidelines. The search strategy focused on identifying quantitative and mixed-methods studies using questionnaires to measure HBV-related stigma and discrimination. Studies published between January 1, 1992, and December 31, 2023, were considered. The selection process involved screening for duplicates, reviewing titles and abstracts, and performing a full-text review based on predetermined eligibility criteria.
RESULTSThe initial search yielded 1,198 articles, with 24 duplicates removed. After title and abstract screening, 28 articles were considered for full-text review, resulting in 17 relevant articles in the final analysis with 15 unique instrumentations. The majority of studies employed cross-sectional designs (n=8), with a significant concentration in Asian countries (n=11), indicating a regional focus in HBV stigma research. The review identified a range of questionnaire methodologies, but most studies lacked specificity regarding the type of stigma measured. The Likert Scale was the most commonly used measurement tool, yet few studies provided cut-off values for stigma levels. Validity and reliability testing was reported in 12 articles, including pilot studies, Cronbach’s alpha, and factor analysis.
CONCLUSIONThe lack of a universal methodology and specificity in existing instruments underscores the importance of developing a refined tool that can accurately capture the nuances of stigma and discrimination associated with HBV. The urgent need for standardized, reliable, and culturally sensitive questionnaires is evident, underscoring their importance in developing effective public health strategies and improving treatment outcomes for individuals living with HBV, especially in the Philippines.
Human ; Social Stigma ; Hepatitis B, Chronic ; State-of-the-art Review ; Review Literature As Topic
4.Prevalence of soil-transmitted helminth, hepatitis A, and Helicobacter pylori infections among municipal solid waste workers in Baguio City.
Mark Gideon M. WALLIS ; Jannette D. AWISAN
Acta Medica Philippina 2025;59(17):24-31
BACKGROUND AND OBJECTIVES
Municipal solid waste workers (MSWWs) are important in the city’s waste management. With these vital contributions, they face unique occupational hazards and health risks. This study aims to determine the prevalence of occupational infections, such as soil-transmitted helminth infections (STHI) and hepatitis A virus (HAV), as well as the occurrence of Helicobacter pylori infection among the MSWWs of Baguio City.
METHODSThis cross-sectional analytic study collected data from volunteer MSWWs using a questionnaire to gather information on age, duration of employment, use of gloves in the workplace, and hand hygiene practices. Stool samples were obtained from participants and were analyzed for STHI using the Formalin Ether Concentration Technique (FECT). H. pylori infection was detected using the SD Bioline rapid antigen test kit on stool samples while blood samples were collected and tested for HAV antibodies using the Aria IgG/IgM rapid test kit.
RESULTSOf the 44 volunteer MSWWs tested, 25 were infected with hazardous pathogens. Specifically, six workers (13.6%) were infected with STHI, four (9.1%) were infected with HAV and 15 (34.1%) were infected with H. pylori. Among those infected with STHI, Ascaris lumbricoides and Endolimax nana were the predominant species, each with a prevalence rate of 33.3%. In contrast, Blastocystis hominis and hookworm infections each had a prevalence rate of 16.7%. A significant association was found between STHI prevalence and the preference for alcohol hand rubs over hand washing, with a p-value of 0.008.
CONCLUSIONThe analysis revealed a significant association between the prevalence of STHI and the preference for alcohol hand rubs over hand washing, suggesting that MSWWs may have a false sense of security regarding their hygiene practices. The findings revealed the critical importance of proper hand washing in preventing STHI. Future research should expand data collection to encompass a broader range of socio-demographic, environmental, and lifestyle factors that may influence infection rates. Additionally, including a control group of individuals not exposed to waste management could help differentiate between factors specific to waste handling and those related to other occupations. This study emphasizes the need for collaborative efforts among researchers, public health authorities, and waste management agencies to enhance the health and safety of MSWWs while addressing broader public health concerns related to waste management practices.
Human ; Hepatitis A Virus ; Helicobacter Pylori
5.Elimination of chronic viral hepatitis C in correctional health.
Rahul KUMAR ; Yu Jun WONG ; Jessica TAN
Singapore medical journal 2025;66(Suppl 1):S70-S74
Correctional facilities are a major hub of hepatitis C virus (HCV), with rates far higher than those observed in the general population. Once considered an intractable crisis, the current situation offers a unique opportunity. The advent of direct-acting antivirals has changed the HCV treatment landscape, making its elimination possible. This review summarises the scientific evidence and progress towards HCV elimination in correctional health systems. It outlines the evolution of 'test-and-treat' models, assesses micro-elimination success worldwide, especially in Singapore, and highlights collaborative efforts between Changi General Hospital and Singapore Prison Services. Their implementation of HCV treatment guidelines serves as a key case study in this context. This review also analyses the various barriers - structural, financial, clinical and logistical - that hinder progress. It consolidates strong evidence that prison-based HCV treatment is cost-effective, promotes health equity, supports the World Health Organization 2030 goals and reduces the societal burden of HCV.
Humans
;
Singapore
;
Antiviral Agents/therapeutic use*
;
Hepatitis C, Chronic/epidemiology*
;
Prisons
;
Prisoners
;
Disease Eradication
;
Cost-Benefit Analysis
;
Hepacivirus
;
Correctional Facilities
6.Analysis of knowledge and related factors regarding hepatitis C prevention and treatment among female sex workers and men who have sex with men in the Xizang Autonomous Region.
Dorji WANGMO ; X Y ZHAO ; J SUN ; J PENG ; S R LI ; N PANG ; X D WU ; H Q GONG ; Y LI ; Y YANG
Chinese Journal of Epidemiology 2025;46(8):1417-1421
Objective: To investigate the knowledge of hepatitis C prevention and treatment and related factors among two groups of female sex workers (FSW) and men who have sex with men (MSM) in the Xizang Autonomous Region (Xizang) to provide a basis for the subsequent development of Hepatitis C publicity and education strategies. Methods: From August to September 2021, a special survey was conducted among 1 244 FSW and 234 MSM in 5 districts (counties) of 4 regions in Xizang. A one-on-one face-to-face questionnaire survey was adopted, and the χ² test and logistic regression were used to analyze the related factors of awareness of hepatitis C prevention and treatment among FSW and MSM. Results: The awareness rates of hepatitis C prevention and treatment knowledge among FSW and MSM were 35.0% (436/1 244) and 11.1% (26/234), respectively. Multivariate logistic regression analysis revealed that the positive related factors of FSW' awareness of hepatitis C prevention and treatment knowledge among those who had high school or technical secondary school education (aOR=4.72, 95%CI: 3.30-6.74) and college education or above (aOR=2.24, 95%CI: 1.58-3.18), those who experienced self-perceived risk of HCV infection (aOR=1.87, 95%CI: 1.43-2.45), negative related factors included married or cohabiting (aOR=0.58, 95%CI: 0.35-0.95), divorce or windowless (aOR=0.44, 95%CI: 0.27-0.72), no condom was used in the most recent commercial sexual activity (aOR=0.54, 95%CI: 0.43-0.69). The positive related factors of MSM's awareness of hepatitis C prevention and treatment knowledge were over 40 years old (aOR=8.65, 95%CI: 3.19-23.42) and having a self-perceived risk of HCV infection (aOR=6.25, 95%CI: 2.50-15.61). Conclusions: The awareness rate of hepatitis C prevention and treatment among FSW and MSM was relatively low in Xizang in 2021 and urgently needs to be improved. It is necessary to formulate targeted publicity strategies based on the characteristics of these two groups of people, increase publicity efforts, and expand the coverage of knowledge publicity to popularize key points about the clinical manifestations, treatment options, and transmission routes of hepatitis C, and carry out necessary warnings and education.
Humans
;
Male
;
Hepatitis C/therapy*
;
Health Knowledge, Attitudes, Practice
;
Surveys and Questionnaires
;
Sex Workers/psychology*
;
Homosexuality, Male
;
Female
;
Adult
;
China
;
Young Adult
;
Middle Aged
;
Logistic Models
7.Post-exposure prophylaxis and follow-up in children and young persons presenting with sexual assault.
Sarah Hui Wen YAO ; Karen NADUA ; Chia Yin CHONG ; Koh Cheng THOON ; Chee Fu YUNG ; Natalie Woon Hui TAN ; Kai-Qian KAM ; Peter WONG ; Juliet TAN ; Jiahui LI
Annals of the Academy of Medicine, Singapore 2025;54(7):410-418
INTRODUCTION:
Paediatric sexual assault (SA) victims should be assessed for post-exposure prophylaxis (PEP) to mitigate the risk of sexually transmitted infections (STIs). We describe the clinical characteristics of children and young persons (CYPs) presenting with SA at KK Women's and Children's Hospital in Singapore, viral PEP (human immunodeficiency virus [HIV] and hepatitis B virus [HBV]) prescribing practices, and STI evaluation at follow-up.
METHOD:
Medical records of CYPs ≤16 years who presented with SA between January 2022 and August 2023 were reviewed, including assault and assailant characteristics, baseline and follow-up STI screening, PEP prescription, adherence and follow-up attendance. CYPs with SA in the preceding 72 hours by HIV-positive or HIV-status unknown assailants with high-risk characteris-tics were eligible for HIV PEP.
RESULTS:
We analysed 278 CYPs who made 292 SA visits. There were 40 (13.7%) CYPs eligible for HIV PEP, of whom 29 (82.9%) received it. Among those tested at baseline, 9% and 34.9% of CYPs tested positive for Chlamydia trachomatis and Gardnerella vaginalis, respectively. None tested positive for Neisseria gonorrhoeae, Trichomonas vaginalis, HIV, HBV or hepatitis C. Majority of CYPs tested were HBV non-immune (n=167, 67.6%); only 77 (46.1%) received the vaccine. Out of 27 CYPs eligible for HBV PEP with immunoglobulin, only 21 (77.7%) received immunoglobulin. A total of 37 CYPs received HIV PEP, including 8 who were retrospectively deemed ineligible. Only 10 (27%) completed the course. Overall, 153 (57.7%) CYPs attended follow-up, and none seroconverted for HIV or HBV.
CONCLUSION
We report suboptimal rates of HBV post-exposure vaccination, and low compliance to HIV PEP and follow-up among paediatric SA victims. Factors contri-buting to poor compliance should be examined to optimise care for this vulnerable population.
Humans
;
Post-Exposure Prophylaxis/methods*
;
Female
;
Child
;
Adolescent
;
Singapore/epidemiology*
;
HIV Infections/prevention & control*
;
Male
;
Sexually Transmitted Diseases/epidemiology*
;
Retrospective Studies
;
Hepatitis B/prevention & control*
;
Follow-Up Studies
;
Child, Preschool
;
Sex Offenses/statistics & numerical data*
;
Child Abuse, Sexual
8.Study on Reentry Strategy and Results of Blood Donors with Single Reagent Reactivity in Wuhan Area.
Ting-Ting XU ; Qin YU ; Song-Qing KE ; Yan CAI ; Song-Li XIE ; Jing XIONG ; Lei ZHAO
Journal of Experimental Hematology 2025;33(2):530-537
OBJECTIVE:
To study the results, re-donation situation and characteristics of single-reagent reactive blood donors who were put into the reentry strategy in Wuhan area, explore the rationality and effectiveness of the current reentry strategy, and provide data support for the improvement of the reentry process of blood donors.
METHODS:
From January 2020 to December 2023, blood donors who conform the reentry criteria and voluntarily applied for returning to Wuhan Blood Center were tested and the results were analyzed. According to the reentry strategy, serological testing and nucleic acid testing were carried out in parallel, serological testing was performed by ELISA with reagents from two different manufacturers, and the primary reactive samples were tested by double-well retest, and HBV/HCV/HIV nucleic acid detection was performed by RT-PCR with an individual donor test mode. Supplementary HBcAb testing was applied for HBV single reagent reactivity by chemiluminescence method. Supplementary TP-WB testing was applied for returning blood donors with repeated TP single reagent reactivity. If returning blood donors with HIV single reagent reactivity were repeated single reagent reactivity, the samples were sent to local CDC for confirmatory test.
RESULTS:
7 098 blood donors were qualified for reentry, 716 donors voluntarily applied for reentry, 436 donors successfully reentry, 251 donors entered the next round, 29 donors could not reentry. The reentry rates for the past four years were 66.67%(42/63), 54.73%(81/148), 60.71%(136/224) and 62.99%(177/281), respectively. Up to December 31, 2023, 275 donors donated blood again, and the donation rates for past four years were 76.19%(32/42), 72.84%(59/81), 61.76%(84/136) and 56.50%(100/177), respectively. After donating blood, 31 donors were disqualified again by blood screening and subjected to permanent deferral. The results of returning to the team had statistical differences in reentry items, educational level, age, and marriage(P < 0.05).
CONCLUSION
The current reentry strategy adopted by the blood donation and supply institution can effectively retain part of blood donors, reduce the negative emotions of blood donors and increase blood resources.
Humans
;
Blood Donors
;
China
;
Hepatitis B
;
Enzyme-Linked Immunosorbent Assay
;
Hepatitis C
;
Male
9.The Correlation between miR451a and Occult Hepatitis B Virus Infection in Voluntary Blood Donors.
Qiang LIU ; Wei YU ; Fang WANG
Journal of Experimental Hematology 2025;33(2):546-551
OBJECTIVE:
To analyze the relationship between miR451a and occult hepatitis B virus infection (OBI) in voluntary blood donors, and to provide ideas for the identification of OBI.
METHODS:
A total of 125 003 blood samples were collected from voluntary blood donors in our center from January 2022 to June 2023, and OBI infection was detected by blood screening. At the same time, 40 HBsAg double reagent reactive samples (S/CO>3.0) were selected as the positive control group, and 40 healthy blood donors were selected as the negative control group (normal group). The plasma miR451a level was detected, and the serum indexes of total bilirubin (TBil), alanine aminotransferase (ALT), aspartate aminotransferase (AST). The relationship between miR451a and OBI were analyzed.
RESULTS:
54 out of 125 003 blood samples were diagnosed as OBI, and the OBI infection rate was 0.043% (54/125 003). Compared with the normal group, the relative expression of plasma miR451a in the OBI group and the positive control group was down-regulated (P < 0.05), but there was no significant difference in the relative expression of plasma miR451a between the OBI group and the positive control group (P >0.05). The HBV DNA load, TBil, ALT and AST levels in the positive control group were higher than those in the OBI group and the normal group (P < 0.05). There was no significant difference in plasma TBil, ALT and AST levels between OBI group and normal group (P >0.05). Logistic regression analysis and receiver operating curve (ROC) showed that plasma miR451a could distinguish OBI group from healthy group, and the area under the curve (AUC) was 0.904 (95%CI : 0.829-0.978). However, plasma miR451a was difficult to distinguish between OBI and HBsAg responders.
CONCLUSION
Plasma miR451a can be used as a potential biomarker for HBV infection, and can be used to identify OBI in HBsAg non-reactive blood donors.
Humans
;
MicroRNAs/blood*
;
Blood Donors
;
Hepatitis B/blood*
;
Hepatitis B virus
;
Alanine Transaminase/blood*
;
Aspartate Aminotransferases/blood*
;
Female
;
Male
;
Adult
;
Hepatitis B Surface Antigens/blood*
10.Relationship between Peripheral Blood TIM-3 and Iron Overload in Patients with Myelodysplastic Syndrome Undergoing Red Blood Cell Transfusion.
Ding-Yun GAN ; Jun WU ; Man ZHOU ; Wan CHEN ; Wen JIANG
Journal of Experimental Hematology 2025;33(3):841-847
OBJECTIVE:
To investigate the relationship between peripheral blood T-cell immunoglobulin mucin-3 (TIM-3) and iron overload in patients with myelodysplastic syndrome (MDS) undergoing red blood cell transfusion.
METHODS:
120 MDS patients who received treatment at Wuhan Third Hospital from June 2020 to May 2022 were included and analyzed as research subjects, all of whom met the indications for red blood cell transfusion. Blood routine and biochemical indicators were tested before transfusion, and general clinical data of the patients were statistically analyzed. The iron metabolism status of the patients were evaluated. The clinical characteristics of patients with iron overload and the factors affecting iron overload were analyzed. And a correlation analysis was conducted between TIM-3 and other factors affecting iron overload.
RESULTS:
Among the 120 MDS patients included in this study, 82 cases (68.33%) were detected to have iron overload after red blood cell transfusion. The occurrence time of iron overload was 20-42 weeks, with an average time of 32.35±5.26 weeks, calculated from the first transfusion of red blood cells. The proportion of patients with high-risk and extremely high-risk according to the revised International Prognostic Scoring System (IPSS-R) and WHO classification-based Prognostic Scoring System (WPSS), the volume of blood transfusions, the proportion of transfusion-dependent patients, and the levels of serum hepcidin (Hepc), erythropoietin (EPO), and TIM-3 in patients with iron overload were higher than those in patients with normal iron metabolism, and the differences were statistically significant (P < 0.05). Logistic regression analysis showed that high-risk and extremely high-risk according to WPSS, blood transfusion volume, transfusion dependence, and upregulation of serum Hepc, EPO, and TIM-3 expression were factors affecting iron overload in MDS patients undergoing red blood cell transfusion (P < 0.05). Pearson correlation analysis showed that serum TIM-3 level in MDS patients were positively correlated with the other factors affecting iron overload (P < 0.05).
CONCLUSION
Serum TIM-3 is associated with iron overload in MDS patients undergoing red blood cell transfusion, and upregulation of serum TIM-3 expression increases the risk of iron overload after red blood cell transfusion.
Humans
;
Myelodysplastic Syndromes/blood*
;
Iron Overload/blood*
;
Hepatitis A Virus Cellular Receptor 2/blood*
;
Erythrocyte Transfusion
;
Male
;
Female
;
Middle Aged
;
Aged
;
Iron


Result Analysis
Print
Save
E-mail